LIVE MARKETS-Headlines round-up: Siemens, KPN, LVMH, Novartis

Jan 30 - Welcome to the home for real-time coverage of European equity markets brought to

you by Reuters stocks reporters and anchored today by Josephine Mason and Helen Reid. Reach them

on Messenger to share your thoughts on market moves:

josephine.mason.thomsonreuters.com@reuters.net and helen.reid.thomsonreuters.com@reuters.net

HEADLINES ROUND-UP: SIEMENS (BSE: SIEMENS.BO - news) , KPN (Amsterdam: KPN.AS - news) , LVMH, NOVARTIS (0715 GMT)

Futures are treading water this morning, indicating a slight dip for the Eurostoxx 50 and

the DAX, while the FTSE 100 is set to get a boost from the weaker pound.

Results from some of Europe's biggest hitters in industrials, luxury, and pharma are likely

to drive stock moves today while investors also look to the start of trade talks between the

U.S. and China, and the Fed.

Weaker results from Siemens could hurt the shares: the industrial conglomerate reported

weaker-than-expected industrial profit for its first quarter due to profits at its power

business plunging.

Siemens' CEO also fired some shots at the EU over the Alstom (LSE: 0J2R.L - news) -Siemens merger facing

regulatory opposition, saying it will be interesting to see if European mobility will be decided

by "backward-looking technocrats" or "future-orientated Europeans"

Dutch telecomms firm KPN also reported earnings that missed estimates and guided to lower

cash flow for this year.

And from after the close yesterday, some cheery results from LVMH could help lift the mood

in the luxury sector: the luxury conglomerate struck a "cautiously" confident tone for the year

ahead as Q4 sales held up despite fears of a China slowdown.

Pharma giant Nobartis said it sees mid-single-digit sales growth from its core businesses in

2019 as it sheds its Alcon eyecare unit and a U.S. generics pills business to focus on newer

high-tech drugs.

Siemens CEO calls on Europe to approve Alstom rail merger

Siemens misses Q1 profit forecast as power problems persist

LVMH reassures on China as Vuitton handbags boost sales

Novartis (IOB: 0QLR.IL - news) sees 2019 growth as it sheds eyecare unit, narrows focus

Lonza Group (LSE: 0QNO.L - news) says profit rise driven by pharma, biotech

KPN Q4 earnings miss estimates; sees lower cash flow in 2019

Santander Q4 net profit 2.07 bln euro

French Q4 growth better-than-expected at 0.3 pct

(Helen Reid)

*****

FTSE BOOST BUT EURO ZONE UNDER PRESSURE (0633 GMT)

We've got a mixed start in Europe this morning, with Frankfurt and Paris under pressure amid

continued caution ahead of policy guidance from the Fed and the latest U.S.-China trade talks

and London drawing support from the weaker pound overnight to extend yesterday's rally following

the Brexit votes in parliament.

We've got an action-packed day with the Fed deciding on interest rates later in the session

and fresh talks between Washington and Beijing over the protracted trade dispute kicking off.

After raising rates gradually last year, the Fed is taking a wait-and-see approach to further

tightening in the face of an overseas slowdown and market volatility.

Tech will remain in focus after Apple (NasdaqGS: AAPL - news) 's results after the closing bell - the iPhone maker,

which warned earlier this month about a slowdown in China, reported sharp growth in its services

business.

Financial spreadbetters expect London's FTSE to open 35 points higher at 6,869, Frankfurt's

DAX to open 4 points lower at 11,215 and Paris' CAC to open 9 points higher at 4,937.

Back in the UK, the market would like more certainty that a no-deal Brexit was off the cards

rather than having to wait for PM May to head back to Brussels to attempt to renegotiate the

terms of the backstop again.

"The market was clearly not cheered by a result that legally keeps no deal on the table,

given that sterling has responded by surrendering some of its recent gains. Investors would have

appreciated a more conclusive view on rejecting such an outcome," said Geoffrey Yu, head of UK

investment office, UBS Global Wealth Management.

"All eyes will turn to the EU as the question now becomes what is achievable in new

negotiations. As things stand, an extension is not entirely unthinkable."

(Josephine Mason)

*****

(Reporting by Josephine Mason, Helen Reid, Julien Ponthus, Danilo Masoni)